Avacta reports new pharmacology data for FAP-Exd (AVA6103) Multiple patient-derived xenograft models with prolonged complete responses associated with sustained release of the exatecan payload within the tumor over five days
RNS Hotlist with Zak Mir: AVCT, KOD, BZT, VLRM, ATC, GENI, ARV & N4P
The Times: The headline rate of inflation fell more than expected in November to a 10-month low – increasing expectations that the Bank of England will cut interest rates tomorrow. The
Early trial success for Avacta (AIM: AVCT) as AVA6000 shows meaningful tumor responses
Faridoxorubicin (AVA6000) Phase 1b cohort demonstrates clinically meaningful tumor shrinkage in patients with salivary gland cancers Preliminary Phase 1b data is in line with Phase 1a data reported at the European Society
Share Talk Weekly Stock Market News Review, Sunday 14th December 2025
The FTSE 100 closed the week down 0.6% after data from the Office for National Statistics showed the UK economy contracted by 0.1%. European markets also finished in negative territory,
Avacta Therapeutics (AIM: AVCT) Preliminary Data in Faridoxorubicin Phase 1b Trial
Avacta Announces the Preliminary Clinical Data in the Faridoxorubicin Phase 1b Trial in the Salivary Gland Cancer Cohort
Welcome Dr. Christina Coughlin, CEO of Avacta Therapeutics, onto The BioHub!
Welcome to the Avetix Group YouTube channel.
Share Talk Weekly Stock Market News Review, Sunday 30th November 2025
In commodities this week, momentum continued to build, with silver prices spiking to a new high of $56.72 per ounce after a 10-hour halt in Comex trading, caused by a cooling
Great Request Show: Zak Mir looks at the charting position of AVCT, EPP, FMET, FCM & KOD
Zak Mir takes a look at the latest charting requests. Today’s selection includes Avacta, EnergyPathways, Fulcrum, First Class Metals, and Kodal Minerals.
Share Talk Weekly Stock Market News Review, Sunday 9th November 2025
London’s FTSE 100 closed at its lowest level in almost two weeks on Friday, dragged lower by steep losses in property and travel stocks. The blue-chip index ended 53 points,
Great Request Show: Zak Mir looks at the charting position of AVCT, GGP & MSMN
Zak Mir takes a charting look at the latest requested stocks. Today’s selection includes Avacta, Greatland, and Mosman.
Share Talk Weekly Stock Market News Review, Sunday 2nd November 2025
UK stock markets closed lower on Friday, easing back after a record-breaking October rally as investors adopted a more cautious stance ahead of the Bank of England’s monetary policy decision and the Government’s Budget this month.
RNS Hotlist with Zak Mir: SVNS, AVCT, KMK, OHGR, NFM, LST, AMGO, ECOB, PLSR & GGP
Solvonis Therapeutics (SVNS), an emerging biopharmaceutical company developing novel medicines for high-burden central nervous system (“CNS”) disorders, announced the appointment of Paul Carter as Non-Executive Director, effective 27 October 2025.